Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€117.55

€117.55

0.730%
0.85
0.730%
€203.96
 
09:31 / Tradegate WKN: A2JH2F / Symbol: KRYS / Name: Krystal Biotech / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Krystal Biotech Stock

Krystal Biotech gained 0.730% compared to yesterday.
Krystal Biotech is currently one of the favorites of our community with 19 Buy predictions and no Sell predictions.
With a target price of 203 € there is a hugely positive potential of 72.69% for Krystal Biotech compared to the current price of 117.55 €.
So far the community has only identified positive things for Krystal Biotech stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Krystal Biotech in the next few years

Pros
?
C******** o* t** e**********
?
S********** s********
?
G***** c******* t* c**********
Cons
?
B****
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Krystal Biotech vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Krystal Biotech 0.730% -2.097% 5.088% -31.993% -23.325% 88.226% -
Ardelyx Inc. 0.060% 6.420% 2.935% -51.738% -32.890% 501.553% -46.258%
Evolus Inc -1.950% -4.430% -5.031% -23.350% -28.095% -30.093% 69.283%
Champions Oncology Inc 7.500% -14.894% 14.286% 29.310% 26.050% -18.367% -25.926%

Comments

Prediction Buy
Perf. (%) -4.93%
Target price 207.048
Change
Ends at 24.06.26

Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $240.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -2.77%
Target price 166.604
Change
Ends at 07.05.26

Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target lowered by analysts at Guggenheim from $195.00 to $189.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 0.73%
Target price 193.049
Change
Ends at 07.05.26

Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $219.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat
Show more